Series A - ArriVent Biopharma - Feb 15, 2022 Funding Round Profile - Cointime

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

ArriVent Biopharma

company

Funding Round

Series A

Money Raised

$ 69M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lyra Capital	-	-	-	Detail
Lilly Asia Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jun 30, 2021	Series A	$ 81M	Lyra Capital,Lilly Asia Ventures	Detail